New Alzheimer's Drug Shown to Be Effective

Wednesday, 17 Jul 2013 12:21 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

An experimental drug to treat Alzheimer's disease proved effective in improving cognitive performance in a mid-stage study, Danish pharmaceutical group Lundbeck, one of the drug's two developer's, said on Tuesday.
The drug, Lu AE58054, showed statistically significant cognitive improvement in a Phase II clinical trial of patients suffering from moderate Alzheimer's, when used as an add-on to the drug donepezil for six months.
Lundbeck is developing the drug jointly with Japan's Otsuka to treat Alzheimer's, a degenerative brain disease that causes progressive memory loss.
"Lu AE58054 potentially represents a new approach to Alzheimer's disease and a continuation of Lundbeck's commitment to addressing this complicated disease," Anders Gersel Pedersen, head of research and development at Lundbeck, said in a statement.
Lundbeck agreed to develop the treatment with Otsuka in March, with hopes that it will help offset falling sales of drugs that are losing exclusivity.
It has said the drug could have the potential to generate sales in the United States of over $1 billion per year, a level that is considered blockbuster for a drug.
Lundbeck and Otsuka will initiate a Phase III clinical program in about 3,000 patients during the second half of 2013.
Donepezil is made by Eisai and Pfizer and sold under the brand name Aricept.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Only 28% of ALS Ice Bucket Donations Used For Research

Sunday, 31 Aug 2014 11:17 AM

The ice bucket challenge to raise support for ALS research has gone viral in recent weeks, drawing celebrities, everyd . . .

Clockwork Pacemaker Works Without Batteries

Sunday, 31 Aug 2014 10:26 AM

Swiss engineers have developed a prototype battery-less pacemaker based on a self-winding wristwatch. . . .

New Cholesterol Drug Cuts Heart Risk in Half

Sunday, 31 Aug 2014 10:15 AM

A new cholesterol-lowering drug roughly halved the number of heart attacks and strokes in a clinical trial, researchers  . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved